🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this investigator-initiated single-site clinical trial is to co...
Status
Recruiting
Location
Main Line Health
Start Date
2024-08-15
Trial ID
NCT06439524
Treatments Being Tested
In this project, the proposition is that the use of daily dosed Myfembree (...
Status
Withdrawn
Location
University of Chicago South Loop
Start Date
2022-11-20
Trial ID
NCT05538689
Treatments Being Tested
This is a retrospective cohort study that will be conducted using secondary...
Status
Active Not Recruiting
Location
SMPA
Start Date
2025-04-30
Trial ID
NCT05739136
Treatments Being Tested
The mechanisms underlying variable efficacy of Relugolix-Combination Therap...
Status
Withdrawn
Location
NorthShore University HealthSystem
Start Date
2024-06-01
Trial ID
NCT06279195
Treatments Being Tested
This is a two-part, open-label, fixed-sequence, two-period crossover drug i...
Status
Completed
Location
Clinical Pharmacology of Miami, An Evolution Research Group Portfolio Company
Start Date
2021-01-06
Trial ID
NCT04714554
Treatments Being Tested
The purpose of this study was to determine the long-term efficacy and safet...
Status
Completed
Location
Andalusia
Start Date
2017-10-19
Trial ID
NCT03412890
Treatments Being Tested
The purpose of this study is to determine the benefit of relugolix 40 milli...
Status
Completed
Location
Andalusia
Start Date
2017-04-26
Trial ID
NCT03049735
The purpose of this study is to determine the benefit and safety of relugol...
Status
Completed
Location
Dothan
Start Date
2017-12-07
Trial ID
NCT03204318
The purpose of this clinical trial to characterize changes in bone mineral ...
Status
Recruiting
Location
Mobile
Start Date
2023-08-14
Trial ID
NCT05862272
Treatments Being Tested
The purpose of this study is to assess the contraceptive efficacy of relugo...
Status
Completed
Location
Mobile
Start Date
2021-03-18
Trial ID
NCT04756037
Treatments Being Tested